These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Oral methotrexate therapy for multiple superficial bladder carcinomata.
    Author: Hall RR, Herring DW, McGill AC, Gibb I.
    Journal: Cancer Treat Rep; 1981; 65 Suppl 1():175-8. PubMed ID: 7326660.
    Abstract:
    Patients with frequently recurring multiple class T1 bladder carcinomata have been treated with methotrexate (MTX) given as 50 mg in syrup every week. In 16 of 17 patients the frequency and number of tumor recurrences have been reduced. Measurement of MTX levels in the urine confirms that this dose of drug yields concentrations that are thought to be cytotoxic for at least 24 hours.
    [Abstract] [Full Text] [Related] [New Search]